BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25688453)

  • 1. Probe-inspired nano-prodrug with dual-color fluorogenic property reveals spatiotemporal drug release in living cells.
    Xue X; Jin S; Zhang C; Yang K; Huo S; Chen F; Zou G; Liang XJ
    ACS Nano; 2015 Mar; 9(3):2729-39. PubMed ID: 25688453
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Dong Y; Du P; Liu P
    Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of doxorubicin release from theranostic macromolecular prodrugs via fluorescence resonance energy transfer.
    Krüger HR; Schütz I; Justies A; Licha K; Welker P; Haucke V; Calderón M
    J Control Release; 2014 Nov; 194():189-96. PubMed ID: 25176577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "AND" logic gate regulated pH and reduction dual-responsive prodrug nanoparticles for efficient intracellular anticancer drug delivery.
    Bai L; Wang XH; Song F; Wang XL; Wang YZ
    Chem Commun (Camb); 2015 Jan; 51(1):93-6. PubMed ID: 25383506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells.
    Cheng Y; Huang F; Min X; Gao P; Zhang T; Li X; Liu B; Hong Y; Lou X; Xia F
    Anal Chem; 2016 Sep; 88(17):8913-9. PubMed ID: 27503607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking.
    Yuan Y; Kwok RT; Zhang R; Tang BZ; Liu B
    Chem Commun (Camb); 2014 Oct; 50(78):11465-8. PubMed ID: 25137179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIE/FRET-based versatile PEG-Pep-TPE/DOX nanoparticles for cancer therapy and real-time drug release monitoring.
    Wang TT; Wei QC; Zhang ZT; Lin MT; Chen JJ; Zhou Y; Guo NN; Zhong XC; Xu WH; Liu ZX; Han M; Gao JQ
    Biomater Sci; 2020 Jan; 8(1):118-124. PubMed ID: 31777865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation-Induced-Emissive Molecule Incorporated into Polymeric Nanoparticulate as FRET Donor for Observing Doxorubicin Delivery.
    Han X; Liu DE; Wang T; Lu H; Ma J; Chen Q; Gao H
    ACS Appl Mater Interfaces; 2015 Oct; 7(42):23760-6. PubMed ID: 26448180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.
    Ikuta Y; Koseki Y; Onodera T; Oikawa H; Kasai H
    Chem Commun (Camb); 2015 Aug; 51(64):12835-8. PubMed ID: 26165183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatiotemporal drug release visualized through a drug delivery system with tunable aggregation-induced emission.
    Xue X; Zhao Y; Dai L; Zhang X; Hao X; Zhang C; Huo S; Liu J; Liu C; Kumar A; Chen WQ; Zou G; Liang XJ
    Adv Mater; 2014 Feb; 26(5):712-7. PubMed ID: 24129910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
    Hu Y; Zeng F
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging-Guided Drug Release from Glutathione-Responsive Supramolecular Porphysome Nanovesicles.
    Xu XD; Zhao L; Qu Q; Wang JG; Shi H; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17371-80. PubMed ID: 26186168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
    Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
    Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer nano-prodrugs with drug release triggered by intracellular dissolution and hydrogen peroxide response.
    Shibata A; Koseki Y; Tanita K; Kitajima S; Oka K; Maruoka K; Suzuki R; Thi Ngoc Dao A; Kasai H
    Chem Commun (Camb); 2024 Jun; 60(50):6427-6430. PubMed ID: 38829169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational analysis by NMR and molecular dynamics of adamantane-doxorubicin prodrugs and their assemblies with β-cyclodextrin: A focus on the design of platforms for controlled drug delivery.
    González-Méndez I; Aguayo-Ortiz R; Sorroza-Martínez K; Solano JD; Porcu P; Rivera E; Dominguez L
    Bioorg Med Chem; 2020 Jul; 28(13):115510. PubMed ID: 32359883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intelligent Janus nanoparticles for intracellular real-time monitoring of dual drug release.
    Cao H; Yang Y; Chen X; Shao Z
    Nanoscale; 2016 Mar; 8(12):6754-60. PubMed ID: 26952741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging intracellular anticancer drug delivery by self-assembly micelles with aggregation-induced emission (AIE micelles).
    Zhang C; Jin S; Li S; Xue X; Liu J; Huang Y; Jiang Y; Chen WQ; Zou G; Liang XJ
    ACS Appl Mater Interfaces; 2014 Apr; 6(7):5212-20. PubMed ID: 24606837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-trigger dual-responsive nanoparticles for controllable and sequential prodrug activation.
    Robertson NM; Yang Y; Khan I; LaMantia VE; Royzen M; Yigit MV
    Nanoscale; 2017 Jul; 9(28):10020-10030. PubMed ID: 28682403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.